FDA Approves Updated COVID-19 Vaccine from Pfizer and BioNTech
The U.S. FDA has approved the XFG-adapted COVID-19 vaccine developed by Pfizer and BioNTech. This approval is a significant public health development, providing an updated vaccine formula for the upcoming 2026-2027 season to address evolving viral strains.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.